Women's Health Initiative (WHI)

Clinical Trial ID NCT00000611

PubWeight™ 535.42‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00000611

Top papers

Rank Title Journal Year PubWeight™‹?›
101 Failure of estrogen plus progestin therapy for prevention. JAMA 2002 1.26
102 Mediterranean and DASH diet scores and mortality in women with heart failure: The Women's Health Initiative. Circ Heart Fail 2013 1.24
103 Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med 2007 1.22
104 Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011 1.22
105 Promoting adherence and retention to clinical trials in special populations: a women's health initiative workshop. Control Clin Trials 2001 1.22
106 Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med 2009 1.21
107 Fatty acid consumption and risk of fracture in the Women's Health Initiative. Am J Clin Nutr 2010 1.16
108 Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative. Am J Clin Nutr 2005 1.14
109 Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study. Fertil Steril 2005 1.13
110 Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr 2005 1.12
111 Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial. J Clin Oncol 2011 1.08
112 Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2010 1.07
113 Predictors of angina pectoris versus myocardial infarction from the Women's Health Initiative Observational Study. Am J Cardiol 2004 1.07
114 Postmenopausal estrogen and progestin effects on the serum proteome. Genome Med 2009 1.07
115 Habitual tea consumption and risk of osteoporosis: a prospective study in the women's health initiative observational cohort. Am J Epidemiol 2003 1.04
116 Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events. Am J Cardiol 2008 1.03
117 Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy. J Clin Oncol 2010 1.03
118 Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women. Metabolism 2003 1.03
119 Dietary adherence in the Women's Health Initiative Dietary Modification Trial. J Am Diet Assoc 2004 1.03
120 Evaluation of the American Heart Association cardiovascular disease prevention guideline for women. Circ Cardiovasc Qual Outcomes 2010 1.02
121 Measurement error corrected sodium and potassium intake estimation using 24-hour urinary excretion. Hypertension 2013 1.01
122 Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol 2012 1.00
123 Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension. J Am Geriatr Soc 2010 1.00
124 Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am J Epidemiol 2011 0.99
125 Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr 2009 0.98
126 Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative. Circulation 2004 0.98
127 Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative. Am J Clin Nutr 2010 0.98
128 Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 2004 0.96
129 Statin use and all-cancer survival: prospective results from the Women's Health Initiative. Br J Cancer 2016 0.95
130 Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. Breast Cancer Res 2014 0.95
131 Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI). Am J Clin Nutr 2011 0.94
132 Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies. Neurology 2014 0.94
133 Racial and ethnic differences in incident hospitalized heart failure in postmenopausal women: the Women's Health Initiative. Circulation 2012 0.94
134 The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004 0.93
135 Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women's Health Initiative). Am J Cardiol 2003 0.93
136 Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr 2013 0.92
137 Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med 2010 0.92
138 Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) study. Circ Heart Fail 2013 0.92
139 High glycemic index diet as a risk factor for depression: analyses from the Women's Health Initiative. Am J Clin Nutr 2015 0.92
140 Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. Am J Clin Nutr 2016 0.91
141 Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. J Clin Hypertens (Greenwich) 2010 0.90
142 Is insurance a more important determinant of healthcare access than perceived health? Evidence from the Women's Health Initiative. J Womens Health Gend Based Med 2000 0.90
143 Factors relating to eating style, social desirability, body image and eating meals at home increase the precision of calibration equations correcting self-report measures of diet using recovery biomarkers: findings from the Women's Health Initiative. Nutr J 2013 0.90
144 Effects of a low-fat dietary intervention on glucose, insulin, and insulin resistance in the Women's Health Initiative (WHI) Dietary Modification trial. Am J Clin Nutr 2011 0.90
145 Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational study. Am J Clin Nutr 2014 0.89
146 Vitamin D intake and lung cancer risk in the Women's Health Initiative. Am J Clin Nutr 2013 0.89
147 The Women's Health Initiative: recruitment complete--looking back and looking forward. J Womens Health 1999 0.88
148 Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. Am J Clin Nutr 2009 0.88
149 Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. J Natl Cancer Inst 2011 0.88
150 The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women's health initiative. J Bone Miner Res 2013 0.88
151 Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial. Cancer Epidemiol Biomarkers Prev 2012 0.88
152 Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes Relat Metab Disord 2004 0.87
153 Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials. Breast Cancer Res Treat 2011 0.87
154 The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative. Nutr Cancer 2008 0.87
155 Differences between estimated caloric requirements and self-reported caloric intake in the women's health initiative. Ann Epidemiol 2003 0.87
156 Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study. Thromb Haemost 2005 0.87
157 Demographic and health factors associated with enrollment in posttrial studies: the Women's Health Initiative Hormone Therapy Trials. Clin Trials 2013 0.86
158 Research staff turnover and participant adherence in the Women's Health Initiative. Control Clin Trials 2003 0.86
159 Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology 2008 0.86
160 Effects of smoking on the genetic risk of obesity: the population architecture using genomics and epidemiology study. BMC Med Genet 2013 0.85
161 Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial. Obstet Gynecol 2006 0.85
162 Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort. Ann Oncol 2014 0.84
163 Antioxidant supplement use in Women's Health Initiative participants. Prev Med 2003 0.84
164 Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy. Circulation 2012 0.84
165 Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke 2012 0.83
166 Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials. Circ Arrhythm Electrophysiol 2012 0.83
167 Relationships between dog ownership and physical activity in postmenopausal women. Prev Med 2014 0.83
168 Development and application of an automated algorithm to identify a window of consecutive days of accelerometer wear for large-scale studies. BMC Res Notes 2015 0.83
169 A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women's Health Initiative. Metabolism 2012 0.83
170 Health characteristics of postmenopausal women with breast implants. Plast Reconstr Surg 2010 0.82
171 Mediterranean and Dietary Approaches to Stop Hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women. Am J Clin Nutr 2013 0.82
172 Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial. Clin Trials 2010 0.82
173 Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases. Genome Med 2013 0.82
174 The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. J Am Diet Assoc 2002 0.82
175 Long-term alcohol and caffeine intake and risk of sudden cardiac death in women. Am J Clin Nutr 2013 0.81
176 Estrogen and dementia: insights from the Women's Health Initiative Memory Study. JAMA 2004 0.81
177 Expression and ambivalence over expression of negative emotion:psychometric analysis in the Women's Health Initiative. J Women Aging 2005 0.80
178 Combined hormone therapy and breast cancer: a single-edged sword. JAMA 2003 0.80
179 Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative. Circ Cardiovasc Qual Outcomes 2014 0.80
180 An exploratory study of respiratory quotient calibration and association with postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2013 0.80
181 Chocolate-candy consumption and 3-year weight gain among postmenopausal U.S. women. Obesity (Silver Spring) 2015 0.80
182 Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women. J Nutr 2014 0.80
183 Insulin Resistance and Risk of Cardiovascular Disease in Postmenopausal Women: A Cohort Study From the Women's Health Initiative. Circ Cardiovasc Qual Outcomes 2015 0.79
184 Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative. Am J Clin Nutr 2015 0.79
185 Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk. Genome Med 2012 0.79
186 Impact of cyclooxygenase inhibitors in the Women's Health Initiative hormone trials: secondary analysis of a randomized trial. PLoS Clin Trials 2006 0.79
187 Development and Use of a Traditional Mexican Diet Score in Relation to Systemic Inflammation and Insulin Resistance among Women of Mexican Descent. J Nutr 2015 0.79
188 Obesity and cancer: the role of vitamin D. BMC Cancer 2014 0.79
189 Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women. Circ Heart Fail 2016 0.78
190 Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol. Int J Geriatr Psychiatry 2011 0.78
191 Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative. Circ Heart Fail 2014 0.78
192 Effect of dietary modification on incident carotid artery disease in postmenopausal women: results from the women's health initiative dietary modification trial. Stroke 2014 0.78
193 Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial. J Clin Oncol 2009 0.78
194 Vitamin D and Diabetic Complications: True or False Prophet? Diabetes Ther 2016 0.78
195 Low-fat diet and skin cancer risk: the women's health initiative randomized controlled dietary modification trial. Cancer Epidemiol Biomarkers Prev 2013 0.78
196 TNF Receptors Predict Hip Fracture Risk in the WHI Study and Fatty Acid Intake Does Not Modify This Association. J Clin Endocrinol Metab 2015 0.78
197 New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk. Arch Intern Med 2009 0.78
198 Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative. Br J Cancer 2016 0.78
199 Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: The Women's Health Initiative Observational Study. BBA Clin 2015 0.78
200 Genetic variation predicts serum lycopene concentrations in a multiethnic population of postmenopausal women. J Nutr 2014 0.77
Next 100